Skip to Main Content

Paper Details

Mitigation of gastrointestinal graft-<i>versus</i>-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination.
Haematologica
3
2023
Author NameAffiliation
Fei TengMemorial Sloan Kettering Cancer Center.
  • 1 - 1

Datasets

Release 1.2